Neuronoprotective action of cortexin andcortagen



Cite item

Full Text

Abstract

The changes of both intracellular resting potential and action potential of the identified neurons of pedal ganglia of the mollusk Planorbarius corneus CNS registered by means of intracellular microelectrodes, and ionic currents of isolated neurons under fixed potential after administration of officinal peptide drug cortexine (cortexine 0.5–1000 µg/ ml and glycine 4–4000 µM), cortexine peptides (0.5–1000 µg/ ml), glycine (0.5 and 5 µM) and tetrapeptide cortagen (0.1–10000 µM) were studied. Both the drug cortexine and cortexine peptides were shown to modulate the electrical activity of neurons by the same manner: moderately changed the resting potential, the action potential and impulse frequency that was interpreted as activating action. Glycine activated neuronal activity as cortexine but in less degree. The mixture of cortexine and glycine (drug cortexine) did not inhibit and did not disturb the functional state of neurons of action, and the hyperpolarization was always observed after administration of peptides as well as the shortening of the action potential, increase of their amplitude and reduction of impulse frequency of neurons. Tetrapeptide cortagen in concentrations 0.1–100 µM also hyperpolarized neurons by 2–3 mV and reduced their spontaneous activity that indicated on its activating (neuronoprotective) action. Cortagen in concentration 1000 µM depolarized the neurons moderately (by 2–4 mV), the increase of impulse activity was registered, and in concentration 10 mM it depolarized neurons significantly and reversible, increasing the frequency and inhibiting the generation of the action potential. Cortagen activated neurons in more degree than cortexine. Cortagen in concentration 0.1 µM also increased the amplitude of slow efflux current by 3–5 %. We did not observe the increased amplitude (activation) of influx sodium and calcium channels after administration of cortagen. A dose-dependent and reversible inhibition of amplitudes of these currents began after administration of cortagen in concentrations 100 µM and more up to 80–90 % inhibition after peptide concentration 10 mM. The inhibition of sodium channels was more intensive than calcium channels. These effects of action of the peptide administered in high concentrations can be qualified as nonspecific and toxic ones.

About the authors

Petr Dmitriyevic Shabanov

Institute of Experimental Medicine, NWB RAMS

Email: pdshabanov@mail.ru
Dr. Med. Sci. (Pharmacology), Professor and Head, Anichkov Dept. of NeuroPharmacology

Anatoliy Ivanovich Vislobokov

Institute of Experimental Medicine, NWB RAMS

Email: vislobokov@yandex.ru
Dr. Med. Sci. (Physiology), Senior Researcher, Anichkov Dept. of NeuroPharmacology

References

  1. Вислобоков А. И., Борисова В. А., Прошева В. И., Шабанов П. Д. Фармакология ионных каналов. — Серия: Цитофармакология. Т. 1 — СПб.: Информ-Навигатор, 2012. — 528 с.
  2. Вислобоков А. И., Игнатов Ю. Д., Галенко-Ярошевский П. А., Шабанов П. Д. Мембранотропное действие фармакологических средств. — Санкт-Петербург–Краснодар: Просвещение-Юг, 2010. — 528 с.
  3. Вислобоков А. И., Игнатов Ю. Д., Канидьева А. А., Мельников К. Н., Середенин С. Б. Влияние противоаритмических препаратов брадизола и амиодарона на ионные токи нейронов прудовика // Мед. акад. журн. — 2004. — Т. 4. С. 16–22.
  4. Вислобоков А. И., Игнатов Ю. Д., Середенин С. Б. Изменения электрической активности нейронов под влиянием афобазола // Эксперим. и клин. фармакол. — 2012. Т. 75, № 6. — С. 3–7.
  5. Дьяконов М. М., Шабанов П. Д. К вопросу о нейропротекторном действии пептидных препаратов // Вестник Рос. воен.-мед. акад. — 2011. — № 1 (33). — С. 255–258.
  6. Камкин А. Г., Киселева И. С. Физиология и молекулярная биология мембран клеток: учеб. пособие. — М.: Академия, 2008. — 592 с.
  7. Лысенко А. В., Арутюнян А. В., Козина Л. С. Пептидная регуляция адаптации организма к стрессорным воздействиям. — СПб: ВМедА, 2005. — 207 с.
  8. Шабанов П. Д. Психофармакологические свойства пептидов с ноотропным типом действия // Мед. акад. журн. — 2009. — Т. 9, № 2. — С. 3–18.
  9. Шабанов П. Д. Доказательность нейропротекторных эффектов полипептидных препаратов: нерешенные вопросы // Нервные болезни. — 2011. — Т. 1, № 4. — С. 17–20.
  10. Шабанов П. Д. Кортексин и другие пептидные нейропротекторы // Инновации в современной фармакологии. Матер. IV съезда фармакологов России. — Казань; М.: Фолиум, 2012. — С. 197.
  11. Шимановский Н. Л., Епинетов М. А., Мельников М. Я. Молекулярная и нанофармакология. — М.: Физматлит, 2010. — 624 с.
  12. Ashcroft F. M. Ion channels and disease. — San Diego: Academic Press, 2000. — 481 p.
  13. Camerino D. C., Tricarico D., Desaphy J. F. Ion channel pharmacology // Neurotherapeutics. — 2007. — Vol. 4, N 2. — P. 184–198.
  14. Catterall W. A. Structure and regulation of voltage-gated Ca 2+ channels // Annu. Rev. Cell Dev. Biol. — 2000. — Vol. 16. — P. 521–555.
  15. Decher N., Pirard B., Bundis F., Peukert S., Baringhaus K. H., Busch A. E., Steinmeyer K., Sanguinetti M. C. Molecular basis for Kv1.5 channel block: conservation of drugs binding sites among voltage-gated K+ channels // J. Biol. Chem. — 2004. — Vol. 279, N 1. — P. 394–400.
  16. Fozzard H. A., Lee P. J., Lipkind G. M. Mechanism of local anesthetic drug action on voltage-gated sodium channels // Curr. Pharm. — 2005. — Vol. 11, N 21. — P. 2671–2686.
  17. Hübner C. A., Jentsch T. J. Ion channel diseases // Hum. Mol. Genet. — 2002. — Vol. 11. — P. 2435–2445.
  18. Lipkind G. M., Fozzard H. A. Molecular modeling of local anesthetic drug binding by voltage-gated sodium channels // Mol. Pharmacol. — 2005. — Vol. 68, N 6. — P. 1611–1622.
  19. Miller K. W. The nature of sites of general anaesthetic action // Br. J. Anaesth. — 2002. — Vol. 89, N 1. — P. 17–31.
  20. Narahashi T. Neuroreceptors and ion channels as the basis for drug action: past, present, and future // J. Pharmacol. Exp. Ther. — 2000. — Vol. 294, N 1. — P. 1–26.
  21. Ragsdale D. S., McPhee J. C., Scheuer T., Catterall W. A. Common molecular determinants of local anesthetic, antiarrhythmic, and anticonvulsant block of voltage-gated Na+ channels // Proc. Natl. Acad. Sci. U S A. — 1996. — Vol. 93. — P. 9270–9275.
  22. Shabanov P. D. Neuroprotective effects of cortexin, a drug derived from the brain cortex // Обз. по клин. фармакол. и лек. терапии. — 2012. — Т. 10, № 2. — С. М97.

Copyright (c) 2013 Shabanov P.D., Vislobokov A.I.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС 77 - 65565 от 04.05.2016 г.


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies